14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 ALDX stock ended at $4.07. This is 2.40% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 2.97% from a day low at $4.05 to a day high of $4.17.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Nov 23, 2016 $5.90 $6.10 $5.86 $5.95 21 283
Nov 22, 2016 $6.45 $6.65 $5.90 $5.90 125 334
Nov 21, 2016 $6.10 $6.90 $5.90 $6.30 93 432
Nov 18, 2016 $5.85 $6.50 $5.85 $6.10 12 446
Nov 17, 2016 $6.30 $6.70 $5.51 $5.75 20 983
Nov 16, 2016 $6.57 $6.70 $6.35 $6.35 35 332
Nov 15, 2016 $6.80 $6.80 $6.35 $6.50 13 433
Nov 14, 2016 $6.45 $6.86 $6.36 $6.85 19 645
Nov 11, 2016 $6.35 $6.35 $6.10 $6.33 28 632
Nov 10, 2016 $6.35 $6.35 $5.70 $6.35 11 954
Nov 09, 2016 $6.20 $6.45 $6.05 $6.20 23 821
Nov 08, 2016 $6.15 $6.15 $6.15 $6.15 27 245
Nov 07, 2016 $5.95 $5.95 $5.95 $5.95 39 400
Nov 04, 2016 $5.30 $5.30 $5.30 $5.30 13 100
Nov 03, 2016 $5.20 $5.20 $5.20 $5.20 11 300
Nov 02, 2016 $5.30 $5.30 $5.30 $5.30 6 900
Nov 01, 2016 $5.40 $5.40 $5.40 $5.40 17 700
Oct 31, 2016 $5.25 $5.25 $5.25 $5.25 15 600
Oct 28, 2016 $5.25 $5.25 $5.25 $5.25 82 900
Oct 27, 2016 $5.70 $5.70 $5.70 $5.70 58 800
Oct 26, 2016 $5.84 $5.84 $5.84 $5.84 72 300
Oct 25, 2016 $6.68 $6.68 $6.68 $6.68 86 900
Oct 24, 2016 $6.86 $6.86 $6.86 $6.86 76 800
Oct 21, 2016 $6.81 $6.81 $6.81 $6.81 14 500
Oct 20, 2016 $6.94 $6.94 $6.94 $6.94 36 000
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT